DB
RVMD icon

Danske Bank’s Revolution Medicines RVMD Stock Holding History

Danske Bank’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8M Buy
79,200
+34,300
+76% +$5.01M 0.03% 377
2026
Q1 		$4.37M Buy
44,900
+41,800
+1,348% +$4.22M 0.01% 536
2025
Q4 		$247K Buy
3,100
+1,000
+48% +$65.6K ﹤0.01% 657
2025
Q3 		$98.1K Hold
2,100
– – ﹤0.01% 867
2025
Q2 		$77.3K Buy
2,100
+1,900
+950% +$73K ﹤0.01% 916
2025
Q1 		$7.07K Hold
200
– – ﹤0.01% 1133
2024
Q4 		$8.75K Sell
200
-500
-71% -$25.2K ﹤0.01% 1125
2024
Q3 		$31.7K Buy
+700
New +$30.5K ﹤0.01% 1272

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Danske Bank's RVMD Position: Q2 2026 in Review

Danske Bank increased its Revolution Medicines (RVMD) stake by 76% in Q2 2026, buying an estimated $5.01M and bringing the position to 79,200 shares worth $14.8M. The position accounts for 0.03% of the portfolio, ranked #377.

Danske Bank first reported a position in RVMD in Q3 2024 and has held it in 8 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Danske Bank held 79,200 shares of Revolution Medicines worth $14.8M as of Q2 2026.
  • Danske Bank bought 34,300 Revolution Medicines shares in Q2 2026, an estimated $5.01M.
  • Revolution Medicines made up 0.03% of Danske Bank's portfolio in Q2 2026, its #377 holding.
  • Danske Bank first reported a position in Revolution Medicines in Q3 2024 and has held it in 8 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.